XTX Topco’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,432
Closed -$12.7K – 3926
2025
Q4
$12.7K Buy
+1,432
New +$17.9K ﹤0.01% 3145
2021
Q4
– Sell
-74
Closed -$32K – 746
2021
Q3
$32K Sell
74
-54
-42% -$24.7K 0.01% 629
2021
Q2
$70K Buy
128
+33
+35% +$14.5K 0.02% 697
2021
Q1
$37K Buy
+95
New +$49.9K 0.02% 639

Other funds holding KRSA

XTX Topco's KRSA Position: Q1 2026 in Review

XTX Topco sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 1,432 shares — an estimated $12.7K sold.

XTX Topco first reported a position in KRSA in Q1 2021 and held it in 4 quarters. The position peaked at $70K in Q2 2021. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.

  • XTX Topco reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 1,432 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $12.7K.
  • XTX Topco first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • XTX Topco's Korsana Biosciences, Inc. Common Stock position peaked at $70K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.